New COVID Shots Same As Old Ones
Two studies performed recently at Columbia University and Harvard University have found that the new COVID-19 bivalent (two-in-one) booster shots developed by Pfizer/BioNTech and Moderna/NIAID do not provide better protection against the BA.4 and BA.5 Omicron subvariant viruses than the original monovalent formulations of the shots.1 2 3 In the Columbia study, 19 people were […]
CDC Advisory Panel Recommends Adding COVID Shots to Child Vaccination Schedule Without FDA License for Use in Children Under 12
On Oct. 20, 2022, the Advisory Committee on Immunization Practices (ACIP) voted 15-0 to add the mRNA COVID-19 shots to the list of vaccines recommended by the U.S. Centers for Disease Control and Prevention (CDC) for children as young as six months old, even though no COVID vaccine has been officially licensed by the U.S. […]
Severe Reactions Minutes After COVID Vaccination Usually Written Off as Coincidental
The U.S. Centers for Disease Control and Prevention (CDC) recommends that everyone who receives a COVID-19 vaccine should be “monitored on site for at least 15 minutes after vaccination.” This is based on the belief that most allergic reactions to vaccines, including severe ones like anaphylaxis, which can lead to unconsciousness, seizures, shock, coma and […]
FDA Authorizes COVID Bivalent Shots for Children as Young as Five Years Old
On Oct. 12, 2022, the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) of the COVID bivalent booster versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID for children as young as five or six years old, respectively. The FDA’s decision on Aug. 31 to grant […]
Getting a Flu Shot and COVID Bivalent Booster Together
Despite President Biden’s recent admission that the COVID-19 pandemic is over, the White House is making another big push to encourage Americans to get yet another COVID booster shot. This time, the Biden administration is marketing the COVID Bivalent versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID respectively.1 2 […]
Study Reveals Much Higher Risk for Serious Adverse Events With mRNA COVID Shots in Clinical Trials
A new study published in the journal Vaccine revealed there was a much higher risk of serious adverse events of special interest for randomized clinical trial participants who received a messenger RNA (mRNA) COVID-19 biologic when compared to participants, who received a placebo for both the Pfizer/BioNTech mRNA BNT162b2 (also known as “Comirnaty”) COVID shot […]